Results 171 to 180 of about 28,018 (262)

Contemporary diagnosis and management of vestibular migraine: a systematic review of conventional and CGRP-targeted therapies. [PDF]

Front Neurol
Alabood S, Aldokhail L, Alotaibi E, Alsaqr M, Alshehri A, Bakry E.   +5 more
europepmc   +1 more source

Effectiveness and Safety of Once‐Weekly Semaglutide 2.4 mg in Korean Adults With Obesity or Overweight: A Multicenter Retrospective Real‐World Study (RE‐SEMA‐K Study)

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 8, November 2026.
ABSTRACT Aims To evaluate the effectiveness and treatment patterns of once‐weekly semaglutide 2.4 mg in South Korean adults with overweight or obesity in real‐world practice. Materials and Methods This multicenter retrospective study analysed electronic medical records from 17 centres in South Korea.
Yu‐Jin Kwon, Young‐Sang Kim, Hae‐Jin Ko, Susie Jung, Yoon Jeong Cho, Ji‐Eun Song, Sung‐Bum Lee, Ga Eun Nam, Jungha Park, Myung Jae Seo, Jong Koo Kim, Seo Young Kang, Yeong Sook Yoon, Soo Hyun Cho, Yonghwan Kim, Hye‐ji An, Seung Hee Kim, Yoo‐Bin Seo, Yong Ho Lee, Seok‐Jae Heo, Jee‐Hyun Kang, Kyoung‐Kon Kim   +21 more
wiley   +1 more source

Durable Benefit or Selective Retention in a Real-World Pediatric Clobazam Cohort [Letter]. [PDF]

Drug Des Devel Ther
Ye T.
europepmc   +1 more source

The Impact of Outcome Measures for Responder Analyses in Placebo‐Controlled Trials of Pharmacological Treatments for Neuropathic Pain

European Journal of Pain, Volume 30, Issue 10, November 2026.
ABSTRACT Background Dichotomous responder outcomes, including ≥ 30% and ≥ 50% pain reduction, patient‐reported pain relief, and Patient Global Impression of Change (PGIC), are widely used in trials assessing interventions for neuropathic pain and have been suggested to be comparable, but their differences and influence on estimated treatment effects ...
Nanna Brix Finnerup, Sandra Sif Gylfadottir, Xavier Moisset, Andrea Truini, Ralf Baron, David L. Bennett, Margarita Calvo, Daniel Ciampi de Andrade, Patrick M. Dougherty, Elena K. Enax‐Krumova, Michael C. Ferraro, Ian Gilron, Aki Hietaharju, David Hohenschurz‐Schmidt, Koichi Hosomi, Harriet I. Kemp, Ewan McNicol, Jules Phalip, Theodore J. Price, Srinivasa N. Raja, Cristina Ramirez Piriz, Andrew S. C. Rice, Blair H. Smith, Nina Taule‐Lim, Jan Vollert, Jan D. Wandrey, Mohammad D. Zunaid, Nadine Attal, Simon Haroutounian   +28 more
wiley   +1 more source

Exudative Retinal Detachments: A Rare Adverse Effect of Topiramate. [PDF]

Clin Case Rep
Aljefri S, Alzakari M, Milibari B, Milibari D.   +3 more
europepmc   +1 more source

Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency

Journal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Primary pyruvate dehydrogenase complex deficiency (PDCD) comprises a group of monogenic disorders caused by pathogenic variants in genes encoding subunits of, or regulatory components affecting, the pyruvate dehydrogenase complex. The clinical phenotype spans a broad continuum, ranging from early onset congenital lactic acidosis to infantile ...
Nandaki Keshavan, Julia Neugebauer, Marcello Bellusci, Enrico Bertini, Garry Brown, Niklas Darin, Suzanne DeBrosse, Lucy Drexler, Stefan Drexler, Gregory M. Enns, Rebecca D. Ganetzky, Kelly Gilbert, Austin Larson, Rebecca Legi, April N. Lehman, Camile Newby, Manuel Schiff, Rachel Skeath, Peter W. Stacpoole, Sarah Thompson, Emma Watt, Saskia B. Wortmann, Jirair K. Bedoyan, Shamima Rahman   +23 more
wiley   +1 more source

Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study. [PDF]

Drug Des Devel Ther
Zhao T, Li HJ, Zhang HL, Yu LH, Yu J, Sun Y, Cheng LF.   +6 more
europepmc   +1 more source

Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population‐Based Matched Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose Seizures and behavioural and psychiatric features may prompt antiseizure medication (ASM) use in dementia. We examined whether increased ASM dispensing precedes or follows initiation of antidementia treatment to inform hypotheses about when these indications emerge.
Osvaldo P. Almeida, Christopher Etherton‐Beer, Frank M. Sanfilippo, David B. Preen, Amy Page   +4 more
wiley   +1 more source

Topiramate-Induced Fanconi Syndrome: A Case Report. [PDF]

Kidney Med
Berlinkova D, Rohatgi R, Rohatgi R, Jiatu AZ.   +3 more
europepmc   +1 more source

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

Addiction, Volume 121, Issue 11, Page 2897-2958, November 2026.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson, Thomas Parkhouse, Chloe Burke, Monika Halicka, Jennifer C. Palmer, Hend Gabr, Rebecca Wilson, Katie E. Webster, Francesca Spiga, Sarah Dawson, Deborah M. Caldwell, Jennifer Scott, Julian P. T. Higgins, Jelena Savović   +13 more
wiley   +1 more source